Bruni Alexander J
Known title: EVP, CFOCIK: 0001949360
Associated companies
Transaction History
| ACH | ▼ Sell | Open Market | 10,568 | $188K | 6/3/2024 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 5,290 | $105K | 5/15/2024 | View on chart |
| ACH | ▲ Buy | Grant | 24,351 | $0 | 3/1/2024 | View on chart |
| ACH | ▼ Sell | Open Market | 12,668 | $223K | 11/10/2023 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 328 | $6K | 8/15/2023 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 1,641 | $31K | 5/15/2023 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 3,219 | $59K | 5/11/2023 | View on chart |
| ACH | ▲ Buy | Grant | 32,384 | $0 | 3/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Accendra Health Receives NYSE Continued Listing Notice
Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.
Accendra Health Receives NYSE Continued Listing Notice. Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.